Development Level

Tbio 3 | 10,625
Tclin 1 | 602

Disease

Cancer 3 | 2,346
ovarian cancer 3 | 8,484
Adenocarcinoma of lung (disorder) 2 | 48
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
non-small cell lung cancer 2 | 2,798
psoriasis 2 | 6,685
Brain Ischemia 1 | 87
Breast cancer 1 | 3,094
CARDIOFACIOCUTANEOUS SYNDROME 3 1 | 1
Carcinoma 1 | 2,147
Cardio-facio-cutaneous syndrome 1 | 6
Cardiofaciocutaneous syndrome 1 | 15
Cardiomyopathy 1 | 110
Contact Dermatitis 1 | 80
Costello syndrome 1 | 16
Costello syndrome (disorder) 1 | 7
Diarrhea 1 | 155
Epidermolytic hyperkeratosis 1 | 13
Hairy Cell Leukemia 1 | 6
Hypermobility syndrome 1 | 17
Infarction, Middle Cerebral Artery 1 | 25
Intellectual disability 1 | 573
LEOPARD Syndrome 1 | 20
Langerhans-cell histiocytosis 1 | 11
Leptospirosis 1 | 17
Lung Neoplasms 1 | 171
Malignant Melanoma with BRAF V600E Mutation 1 | 4
Malignant Melanoma with BRAF V600K Mutation 1 | 2
Melanoma 1 | 261
Metastatic malignant melanoma 1 | 9
Multiple Sclerosis 1 | 498
Multiple myeloma 1 | 1,327
Myocardial Ischemia 1 | 169
Noonan Syndrome 1 | 33
Pasteurellosis 1 | 12
Pick disease 1 | 1,893
Pneumonia 1 | 133
Status Epilepticus 1 | 85
Vascular disease 1 | 281
Wiskott-Aldrich syndrome 1 | 27
active Crohn's disease 1 | 918
acute myeloid leukemia 1 | 780
adrenocortical carcinoma 1 | 1,427
astrocytic glioma 1 | 2,241
astrocytoma 1 | 1,493
atypical teratoid / rhabdoid tumor 1 | 4,369
chronic lymphosyte leukemia 1 | 232
dermatomyositis 1 | 933
ependymoma 1 | 2,514
gastric cancer 1 | 430
glioblastoma 1 | 5,572
glioblastoma multiforme 1 | 347
group 4 medulloblastoma 1 | 1,875
inflammatory breast cancer 1 | 404
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
lung adenocarcinoma 1 | 2,713
medulloblastoma 1 | 1,524
medulloblastoma, large-cell 1 | 6,234
mucosa-associated lymphoid tissue lymphoma 1 | 480
nephrosclerosis 1 | 329
non diabetic and post-ischemic heart failure 1 | 200
oligodendroglioma 1 | 2,849
pancreatic cancer 1 | 2,300
pancreatic carcinoma 1 | 567
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pituitary cancer 1 | 1,972
posterior fossa group B ependymoma 1 | 1,530
primary pancreatic ductal adenocarcinoma 1 | 1,271
primitive neuroectodermal tumor 1 | 3,031
pterygium 1 | 74
subependymal giant cell astrocytoma 1 | 2,287
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 2 | 11,971
Kinase 1 | 634
Transcription Factor 1 | 1,400

Grant Application

5R01CA081064-06 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Dual specificity mitogen-activated protein kinase kinase 1 MAP2K1 Tclin Kinase -3.02798 808.6 1868
C4b-binding protein alpha chain C4BPA Tbio Non-IDG -2.46627 274.1 138
Elafin PI3 Tbio Non-IDG -2.97811 944.1 161
Transcription factor jun-B JUNB Tbio Transcription Factor -1.91865 62.8 567